Skip to main content
SNNVF logo

Sunniva Inc. (SNNVF) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0001 $0.00 (0.00%)
Vol: 10| 52-wk range: $0.00001 – $0.0001
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Sunniva Inc. (SNNVF) trades at $0.0001. Sunniva Inc. is a vertically integrated cannabis company operating in Canada and the United States. Sector: Healthcare.

Price as of · Last analyzed: Mar 16, 2026
Sunniva Inc. is a vertically integrated cannabis company operating in Canada and the United States. The company focuses on cultivation, production, and distribution of therapeutic cannabis solutions under the Sun Fire, Kyndness, and Herbella brands.

Analyst Coverage for SNNVF: SNNVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the SNNVF film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Sunniva Inc. (SNNVF) Healthcare & Pipeline Overview

CEOAnthony F. Holler
Employees148
HeadquartersVancouver, CA
IPO Year2018

Sunniva Inc. is a vertically integrated cannabis company involved in the cultivation, production, and distribution of therapeutic solutions in Canada and the United States. Operating through patient counseling, merchandising, and cultivation segments, Sunniva offers products under the Sun Fire, Kyndness, and Herbella brands, navigating a competitive and evolving market landscape.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for SNNVF?

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Sunniva Inc. presents a speculative investment opportunity within the cannabis sector, characterized by high growth potential and significant risks. As of 2026, the company's negative P/E ratio of -0.17 and a profit margin of -154.6% indicate ongoing challenges in achieving profitability. However, a gross margin of 41.5% suggests potential for improved financial performance with optimized operations and increased sales volume. Growth catalysts include expanding distribution networks in Canada and the United States and introducing new product lines under the Sun Fire, Kyndness, and Herbella brands. The company's vertically integrated model could provide a competitive advantage by controlling costs and ensuring product quality. Key risks include regulatory uncertainties in the cannabis industry, intense competition from established players like CANSF (Cannabis Strategic Ventures) and CXXIF (CANXUS Corp), and the need for substantial capital investment to scale operations.

Based on FMP financials and quantitative analysis

SNNVF Key Highlights

AI-written as of Mar 16, 2026 — figures and tone reflect the data available then, not today's score.

Vertically integrated operations across patient counseling, merchandising, and cultivation & extraction segments.

  • Product portfolio includes Sun Fire, Kyndness, and Herbella brands, targeting diverse consumer segments.
  • Gross margin of 41.5% indicates potential for profitability with optimized operations.
  • Presence in both Canadian and United States cannabis markets provides geographic diversification.
  • Founded in 2014, demonstrating a relatively young company in a rapidly evolving industry.

Who Are SNNVF's Competitors?

SNNVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
CANSF Atlas Energy Corp. $0.09 +12.82% $31.0M —
CXXIF C21 Investments Inc. $0.26 -0.11% $31.4M —
TAK Takeda Pharmaceutical Company Limited $17.86 0.00% $56.8B 64 5-pillar
TEVA Teva Pharmaceutical Industries Limited $39.53 +0.56% $46.0B 66 5-pillar
HLN Haleon plc $8.80 +0.92% $38.8B 78 5-pillar
ZTS Zoetis Inc. $69.69 +0.85% $29.2B 87 5-pillar
VTRS Viatris Inc. $17.60 +0.80% $20.5B 32 5-pillar
ELAN Elanco Animal Health Incorporated $22.14 +1.70% $11.1B 33 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SNNVF's Key Strengths?

Vertically integrated operations.

  • Established brands (Sun Fire, Kyndness, Herbella).
  • Expertise in patient counseling.
  • Presence in both Canadian and US markets.

What Are SNNVF's Weaknesses?

Negative profit margin (-154.6%).

  • Limited market share compared to larger competitors.
  • Reliance on regulatory approvals.
  • High capital requirements for expansion.

What Are the Key Risks for SNNVF?

Financial-distress signal — its Altman Z-Score of -1.59 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-48.7%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Regulatory uncertainties in the cannabis industry could impact Sunniva's operations and profitability.
  • Intense competition from established players may limit Sunniva's market share and pricing power.
  • Fluctuations in cannabis prices could affect Sunniva's revenue and profit margins.
  • High capital requirements for expansion may strain Sunniva's financial resources.
  • Dependence on regulatory approvals for new products and market entry.

What Are SNNVF's Competitive Advantages?

  • Vertically integrated operations provide cost control and quality assurance.
  • Established brands (Sun Fire, Kyndness, Herbella) create customer loyalty.
  • Expertise in patient counseling differentiates from competitors.
  • Strategic partnerships with distributors and retailers expand market reach.

What Does SNNVF Do?

Founded in 2014 and headquartered in Vancouver, Canada, Sunniva Inc. is a vertically integrated cannabis company focused on the cultivation, production, and distribution of therapeutic cannabis solutions. Originally named Sunniva Holdings Corp., the company rebranded in August 2017 to Sunniva Inc., signaling a strategic shift towards its current operational model. The company operates across three key segments: Patient Counselling, Merchandising, and Cultivation & Extraction, allowing it to control the entire value chain from seed to sale. Sunniva's product portfolio includes a range of cannabis products marketed under the Sun Fire, Kyndness, and Herbella brands, targeting different consumer segments and therapeutic needs. The company's vertically integrated approach enables it to maintain quality control, optimize production costs, and adapt to changing market demands in both Canada and the United States. Sunniva aims to establish a strong presence in the cannabis market by offering diverse product lines and leveraging its integrated operations. The company's focus on therapeutic solutions underscores its commitment to providing cannabis products for medical and wellness purposes.

What Products and Services Does SNNVF Offer?

  • Cultivates cannabis plants in controlled environments.
  • Extracts cannabinoids from cannabis plants.
  • Manufactures cannabis-infused products.
  • Distributes cannabis products to retailers and dispensaries.
  • Provides patient counseling services for medical cannabis users.
  • Markets and sells cannabis products under the Sun Fire, Kyndness, and Herbella brands.

How Does SNNVF Make Money?

  • Vertically integrated operations from cultivation to retail.
  • Generates revenue through the sale of cannabis products.
  • Provides patient counseling services for additional revenue.
  • Focuses on both medical and recreational cannabis markets.

What Industry Does SNNVF Operate In?

Sunniva Inc. operates within the rapidly growing cannabis industry, which is characterized by increasing legalization, evolving regulations, and intense competition. The market is driven by rising consumer demand for both medical and recreational cannabis products. Companies like Sunniva are positioning themselves to capitalize on this growth through vertically integrated operations and diverse product offerings. The competitive landscape includes established players such as CANSF (Cannabis Strategic Ventures) and emerging companies focused on specific segments of the cannabis value chain. Market trends include the increasing acceptance of cannabis for therapeutic purposes and the development of innovative cannabis-infused products.

Who Are SNNVF's Key Customers?

  • Medical cannabis patients seeking therapeutic solutions.
  • Recreational cannabis users.
  • Retail dispensaries and cannabis stores.
  • Wholesale distributors of cannabis products.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Mar 16, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
FY2026 est

Forward Outlook

Wall Street analysts project Sunniva Inc. revenue of about $17.7M for fiscal 2026, with EPS near $-0.88.

ROE -49%

Key Financial Metrics

Return on equity for Sunniva Inc. stands at -48.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -23.2%, showing how much profit it generates from its asset base. A current ratio of 0.93 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 3/9

Financial Health

Sunniva Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.59 places it in the distress zone, a signal of elevated financial risk.

Company Profile

Sunniva Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Anthony F. Holler. SNNVF has traded publicly since 2018.

SNNVF Financials

Fundamental Snapshot

Return on Equity (TTM)
-48.7%
Current Ratio
0.9

Based on FMP financials and quantitative analysis

SNNVF Latest News

No recent news available for SNNVF.

SNNVF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SNNVF.

Price Targets

Wall Street price target analysis for SNNVF.

SNNVF MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SNNVF; grades run from A+ (80-100) to F (below 30).

Leadership: Anthony F. Holler

CEO

Anthony F. Holler serves as the CEO of Sunniva Inc., leading a team of 148 employees. His background includes extensive experience in the cannabis industry, with a focus on strategic planning, operational management, and business development. Prior to joining Sunniva, Holler held leadership positions in various cannabis companies, where he oversaw cultivation, extraction, and distribution operations. He possesses a strong understanding of the regulatory landscape and market dynamics in both Canada and the United States.

Track Record: Under Anthony Holler's leadership, Sunniva Inc. has focused on expanding its product portfolio and distribution network. Key achievements include the launch of new cannabis-infused products under the Sun Fire, Kyndness, and Herbella brands, as well as the establishment of strategic partnerships with distributors and retailers. Holler has also overseen efforts to optimize cultivation and extraction processes to improve product quality and reduce production costs.

SNNVF OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Sunniva Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the lack of transparency and potential for fraud or manipulation. This contrasts sharply with NYSE/NASDAQ listings, which demand rigorous compliance and reporting.

  • OTC Tier: OTC Other
Liquidity: Liquidity for Sunniva Inc. shares on the OTC market is likely to be limited, given its status on the OTC Other tier. This can result in wider bid-ask spreads and greater difficulty in buying or selling shares without significantly impacting the price. Low trading volume can also increase the volatility of the stock, making it more susceptible to price swings. Investors should be aware of these liquidity risks before investing in SNNVF.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in SNNVF.
  • Low trading volume can lead to price volatility and difficulty in buying or selling shares.
  • Potential for fraud or manipulation due to lack of regulatory oversight.
  • Higher risk of delisting or suspension of trading.
  • Limited access to capital and financing options.
Due Diligence Checklist:
  • Verify the company's financial statements and audit reports.
  • Research the background and experience of the company's management team.
  • Assess the company's business model and competitive position.
  • Review the company's regulatory filings and compliance history.
  • Check for any legal or regulatory issues involving the company.
  • Monitor trading volume and price activity for signs of manipulation.
  • Consult with a financial advisor before investing.
Legitimacy Signals:
  • Vertically integrated operations demonstrate a commitment to the cannabis industry.
  • Established brands (Sun Fire, Kyndness, Herbella) suggest a focus on product quality.
  • Presence in both Canadian and US markets indicates geographic diversification.
  • Company has been in operation since 2014.

What Investors Ask About Sunniva Inc. (SNNVF) — Healthcare

What do analysts say about SNNVF stock?

As of March 16, 2026, there is no readily available analyst consensus on SNNVF stock due to its OTC listing and limited coverage. However, the gross margin of 41.5% suggests potential for improved financial performance.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • OTC market data may be limited and less reliable than data for exchange-listed companies.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis